← Back to all trials
Not Yet Recruiting
NCT05665777
Chinese Medicine for Treating Chronic Pharyngolaryngitis
Conditions: Chronic Pharyngolaryngitis (Disorder)
Sex: All
Ages: 18 Years – N/A
Phase: PHASE2
Enrollment: 74
Sponsor: Chinese University of Hong Kong
Summary
A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine formula in treating Chronic pharyngolaryngitis.
Subjects will be randomized into a treatment group or placebo group for 8 weeks, and then followed by an 8-week post-treatment visit.
Eligibility Criteria
Inclusion Criteria:18 years of age or above (Chinese subjects only);Persistent symptoms of pharyngitis (sore throat, globus, dry throat, dry cough, throat irritation) for more than 3 weeks;Determined to be the following Chinese medicine syndromes by Registered Chinese Medicine Practitioners (RCMPs): Wind-heat invading the upper-jiao, or phlegm heat or Yin deficiency;Visual analog scale (VAS) score for pain ≥ 50 mm;Numeric rating scale (NRS) ≥ 6; andBe able to give voluntary written informed consent.Exclusion Criteria:Known severe medical conditions, such as cardiovascular, liver or renal dysfunction, diabetes mellitus, cancers, cerebrovascular diseases, blood system diseases;Concomitant use of steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and immunotherapy within the past week;Impaired hematological profile and liver / renal function exceed the upper limit of the reference value by 2 times;Known Allergic rhinitis;Known Gastroesophageal Reflux Disease (GERD);Known cancer or suspected cancer of throat/oesophagus;Mechanical obstruction of the throat accountable for the symptoms;Known alcohol and/or drug abuse;Known allergic history to any Chinese herbal medicines; andSubjects who are known pregnant or lactating.
Source: ClinicalTrials.gov (NCT05665777). StuddyBuddy aggregates publicly available trial information.